Influence of the Anionic Part of 1-Alkyl-3-Methylimidazolium-Based Ionic Liquids on the Chromatographic Behavior of Perazine in RP-HPTLC by Mieszkowski, Dominik et al.
Journal of Liquid Chromatography & Related Technologies, 38: 1499–1506, 2015
Copyright # Taylor & Francis Group, LLC
ISSN: 1082-6076 print/1520-572X online
DOI: 10.1080/10826076.2015.1063508
Influence of the Anionic Part of 1-Alkyl-3-Methylimidazolium-
Based Ionic Liquids on the Chromatographic Behavior of
Perazine in RP-HPTLC
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Department of Medicinal Chemistry, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Bydgoszcz, Poland
1-Alkyl-3-methylimidazolium-based ionic liquids (tetrafluoroborate, L-(þ)-lactate and ethyl sulfate) were used as mobile phase additives
to assess the effect of its anionic part on the retention mechanism of perazine in pharmaceutical formulation in reversed-phase high-
performance thin-layer chromatography (RP-HPTLC) method. In all cases, significant changes and improvements in the retention
factor were observed when ionic liquids were added to the mobile phase. We found that the chromatographic behavior of the basic
analyte depends on the utilized ionic liquid as well as its various anions. Enhancement of separation confirms silanol suppressing
potency of employed ionic liquids and their positive impact on chromatographic separation of basic drugs. Among selected ionic
liquids, the optimum distribution parameters such as shape and quality of spots, high precision, and accuracy in qualitative and
quantitative determination characterize the system with [EMIm][BF4] as mobile phase modifier. Our proposed HPTLC method for
determination of perazine in oral tablets was also subjected to subsequent validation procedure in accordance with ICH guidelines and
proved to be suitable, inexpensive, and convenient method in a pharmaceutical analysis.
Keywords: basic drugs, ionic liquids (ILs), mobile phase modifiers, perazine, pharmaceutical analysis, reversed-phase high-performance
thin-layer chromatography (RP-HPTLC)
Introduction
Reversed-phase liquid chromatography (RP-LC) of basic drugs
may cause numerous difficulties in the chemical and pharma-
ceutical analysis due to the strong interactions between these
compounds and silica-based stationary phases. Poor peak shape
or peak tailing, band broadening, and change in retention time or
retardation factor are typical examples of problems which may
occur in liquid chromatography separation.[1–3]
Improvement of the quality of separation and enhancing its
efficiency can be achieved using various types of mobile phase
modifiers, such as amines. The most popular are ammonia and
short chain organic amines such as diethylamine (DEA), triethy-
lamine (TEA), or longer chain compounds as N,N-dimethyloc-
tylamine (DMOA).[3–6] These additives were successfully used
as tailing suppressors and chromatographic separation with their
use resulted in shortened retention time and improvements in
peak shapes of peptides and basic compounds like alkaloids,
b-blockers, antipsychotic, and antidepressant drugs.[5–10] How-
ever, much more attention is recently directed toward ionic
liquids (ILs) rather than ammonium compounds in the separ-
ation and analysis process.[1–3,11–13] In a comparative study
reported by Ruiz-Angel et al.,[11] ILs have proven to be even
better additive compared to TEA when assessing peak
efficiency and its shape. Similarly, Kaliszan et al.[3]
demonstrated the advantages of the use of imidazolium ILs in
thin-layer system over the conventional chromatographic modi-
fiers like NH4OH, TEA, and DMOA. As shown in the afore-
mentioned study, 1-alkyl-3-methylimidazolium-based ILs,
particularly the imidazolium ring, significantly increased the
mobility of basic analytes by their ability to compete with them
and suppress free silanols on octadecylsilica TLC-plates and so
remove the specific interactions between the negatively charged
silanol groups and basic drugs.
ILs is a term generally related to the compounds made solely
of ions: large asymmetric organic cations and inorganic or
organic counterions, whose melting temperature are below 100°
C or sometimes even below room temperature (RTILs).[1,2,12]
ILs have negligible vapor pressure, therefore they do not release
noxious substances into the environment and are classified as
“green chemistry” materials.[12] The diversity of chemical struc-
ture of these compounds and the possibility of a combination of
the cation–anion is truly enormous and can lead to many unique
properties, which will reflect on their subsequent use in almost
every field of modern chemistry: including organic synthesis,
electrochemistry, catalysis, biocatalysis, chromatography, and
others.[2,12]
Chromatographic determination of lipophilicity parameters
might be of special importance for search for new drugs. The
parameters obtained by use of liquid chromatography techniques
can predict their potential application because correlate with
drug bioactivity.[13] In practice, the most reliable chromato-
graphic parameters for assessment lipophilicity of drugs are
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determined with the use of RP-LC.[14,15] Lipophilicity data from
classical TLC are rather limited reproducibility.[16] The use of
modern small-diameter particles stationary phase resulted in
development of HPTLC. But correlation between retention para-
meters from HPTLC and reference lipophilicity parameters are
often poor. Recently, imidazolium-based ILs additives appeared
interesting from the point of view of determination of lipophili-
city of ionized forms of basic drugs.[3,17]
In this study we have used commercially available ILs: 1-
ethyl-3-methylimidazolium tetrafluoroborate, 1-ethyl-3-methy-
limidazolium L-(þ)-lactate, and 1-ethyl-3-methylimidazolium
ethyl sulfate in a chromatographic experiment to assess the
influence of different ILs mobile phase additives on the final
results of chromatographic separation of biologically active
compounds.
Perazine chemically defined as 10-[3-(4-methylpiperazin-1-
yl)propyl]phenothiazine (Figure 1) served as the test compound.
It is a widely used basic phenothiazine derivative, known for its
antipsychotic potential to treat moderate or severe mental disor-
ders. Perazine mechanism of action is associated mainly with its
moderate antagonistic affinity with D2-dopaminergic receptors,
but also weak antagonistic activity with respect to D1-dopami-
nergic, a1-adrenergic, 5-HT2-serotonergic, and also M1-muscari-
nic receptors.[18,19] Various methods have been previously
employed for the determination of perazine and other neuroleptic
drugs in pharmaceutical formulation or biological samples.
These methods include: chromatography,[20–22] capillary electro-
phoresis,[21] spectrofluorimetry,[23] and spectrophotometry.[24,25]
The reported results mostly described methods of monocompo-
nent formulation assay. Comparing with Polish Pharmacopoeia
VI TLC method[22] for perazine determination our system is eco-
friendly – we replaced organic phase into more aqueous – butan-
1-ol/NH4OH 17 g/l (5:1) vs. ACN/H2O (6:4). Moreover, as
mentioned above, ILs utilized in the study possess good physico-
chemical properties as they have no vapor pressure and are con-
cerned as nonvolatile compounds and so are classified as “green”
solvents. Though HPLC methods are very precise, accurate[20,21]
– quantification limit level at ng/ml – they are time, solvents, and
work-consuming. Here, we decided to develop rapid with
minimal sample clean-up but still satisfactory HPTLC method
which can be useful for simultaneously quantification of neuro-
leptics (like perazine). This is the first reported method with the
use of IL as a modifier of mobile phase for perazine quantifi-
cation by HPTLC method. For this purpose, densitometry
scanning was used – non-destructive method with high
repeatability – where it is easily to recreate it at any time, any
place as silica plates can be stored for a long time. Our HPTLC
analysis found to be easily accessible and can be considered as an
alternative to spectroscopic methods of determination,[23–25]
however when connected with MS-interface it could bring even
more accurate analysis results. Hence, the proposed HPTLC
method with the IL-based mobile phase might be of special
importance for the simultaneous studies of mixtures of
neuroleptics.
Here, we have developed and validated in accordance with
ICH guidelines[26] method for determination of perazine in a
commercially available pharmaceutical formulation using 1-
alkyl-3-methylimidazolim-based ILs as mobile phase modifiers
in reversed-phased high-performance thin-layer system. To our
knowledge, this is the first planar liquid chromatography method
published for any perazine drug formulation with the use of IL in
the mobile phase system. However, the main aim of the study is
to evaluate the effect of different 1-alkyl-3-methylimidazolium-
based ILs counterions (tetrafluoroborate, L-(þ)-lactate and ethyl
sulfate) in the separation process. Because it should be noted that,
due to their dual nature not only cationic but also anionic part of
IL can affect the chromatographic results in a specific manner by
suppressing interactions between the analyte and silanol groups
of the stationary phase. Use of the two-retention site model
proposed by Nahum and Horvàth enabled a reliable determi-
nation of the silanol-suppressing potency of ILs as mobile phase
modifiers in HPLC and confirmed the influence of both the anion
and the cation of IL on the retention as well as peak shape of
basic drugs.[1,11,27–31] Also, other studies showed that the
Fig. 1. The chemical structures and abbreviations of perazine and the imidazolium ionic liquids.



















































alkyl-imidazolium tetrafluoroborate class ILs with short alkyl-
chain lengths are particularly suitable as modifiers in HPTLC.[32]
Experimental
Chemicals and Reagents
Perazine reference standard as perazine dimalonate was obtained
from LGC Germany GmbH (Luckenwalde, Germany). 1-Ethyl-
3-methylimidazolium tetrafluoroborate ([EMIm][BF4]) and 1-
ethyl-3-methylimidazolium L-(þ)-lactate ([EMIm][Lac]) were
from Sigma-Aldrich (St. Louis, MO, USA). 1-Ethyl-3-methyli-
midazolium ethyl sulfate ([EMIm][EtOSO3]) was supplied by
Solvent Innovation GmbH (Köln, Germany). Methanol and
acetonitrile (HPLC grade) were from Sigma-Aldrich (St. Louis,
MO, USA), whereas deionized water as a solvent was prepared
by Millipore Milli-Q Integral Water Purification System.
Pharmaceutical formulation: Perazin 0.1 tablets (labeled to
contain 100mg of perazine equivalent to 168.4mg of perazine
dimalonate) was purchased from the local pharmacy, brand
name Hasco-Lek (Wrocław, Poland).
Structures of perazine and the ILs used in this study are
shown in Figure 1.
Standards Preparations
Stock solution of perazine dimalonate containing 1.0mgmL1
was prepared by dissolving 15mg of drug standard in 15mL
freshly prepared deionized water followed by 15min of bath soni-
cation until complete dissolution of the drug. The solution was
further diluted with the same solvent to obtain standard solutions
with different concentration in range of 0.20–0.55mgmL1.
These dilutions were stored at 4°C. Each solution was applied
in triplicate in the volume of 4 μL on a plate yielding adequate
amount of perazine per spot and an eight-point calibration curve
was plotted in a range of 0.80–2.20 µg (Figure 6).
Equipment and Chromatographic Conditions
Reversed-phase high-performance thin-layer chromatography
(RP-HPTLC) was performed on chromatographic plates
precoated with octadecylsilica gel (60 RP-18 F254, 20 10 cm)
manufactured by Merck (Darmstadt, Germany) using densito-
metry scanning with a reflectance mode and extinction as an
evaluation parameter by Desaga HPTLC CD 60 densitometer
(Wiesloch, Germany) coupled with a Desaga ProQuant software
(Wiesloch, Germany).
Perazine solutions were spotted on a RP-18 plates in the form
of bands of 5mm width with a HPTLC applicator AS 30 by
Desaga (Wiesloch, Germany) and a 25 μL syringe from Innova-
tive Labor Systeme GmBH (Stützerbach, Germany). Samples
were applied at the constant rate 20 μL s1 and 10mm gap
between them was kept. Plates were developed in glass cham-
bers, previously saturated (for 25min) with vapor of three
various mobile phases containing acetonitrile and water but
differing deployed IL modifier from a group of 1-ethyl-3-
methylimidazolium-based ILs, and more precisely varying his
anionic part (tetrafluoroborate, L-(þ)-lactate or ethyl sulfate).
The mean distance of a chromatographic run was 8 cm and its
separation process was carried out at room temperature (20°C
 1°C). The developed octadecylsilica gel plates with spots
were dried with a help of air dryer for 5min and followed by
densitometric analysis using deuterium lamp as a light radiation
source, with slit height and width set at 1.0 and 4.0, respectively.
The detection process was performed at kmax¼ 247 nm.
Linear regression was determined based on the data of peak
areas and concentration of the corresponding standard per spot.
The measurements of eight-point calibration curve were
repeated three times (Table 1).
The analysis of chromatograms and developed RP-plates
were performed using Desaga CabUV-VIS (Wiesloch,
Germany). The plates were visualized by a digital camera Canon
Power Shot G5 combined with Desaga ProViDoc 3.0 software
(Wiesloch, Germany).
Tailing factor (Tf) was calculated according to the equation
Tf¼ (a þb)/2a, where a and b are the front and back half-widths
at the 5% of the peak height.
Preparation of Sample Solutions
Twenty tablets of Perazin 0.1 were weighed and grounded in a
mortar and an accurately weighed amount of powder
Table 1. Comparison of quantitative determination of perazine dimalonate in tablets with different mobile phase modifiers investigated by
RP-HPTLC with densitometry scanning at 247 nm
[EMIm][BF4] [EMIm][EtOSO3] [EMIm][Lac]
Mobile phase pHa 4.31 7.47 9.16
Range (µg spot1)b 0.80–2.20 0.80–2.20 0.80–2.20
Regression equationa y¼ 1217.6x 265.83 y¼ 1502.1x 525.91 y¼ 1435.6x 739.65
Rc 0.9979 0.9981 0.9747
Mean declared (ng)d 1.50 1.50 1.50
Mean found (ng)e 1.51 1.48 1.43
Recovery (%) 100.66 98.78 95.43
RSD (%) 3.66 4.13 6.97
aAverage, n¼ 3.bEach concentration was obtained minimum from 9 assay (3 determinations/3 independent plates).
cPearson's correlation coefficient.
dLabel claimed from pharmaceutical formulation.
eAmount found from tablets extract.



















































corresponding to 37.5mg of perazine dimalonate were extracted
with 80mL of water in a 100mL flask. The powder was shaken
for 20min, diluted with water to the final volume, then filtrated
using 0.45 µm sterile filters to remove any insoluble particles.
The resulting solution of perazine dimalonate (0.375mgmL1)
was used for chromatographic analysis. Preceding extract was
spotted on a silica-based plate (4 μL equivalent to 1.5 µg per
spot) and analyzed by RP-HPTLC method.
Results
Study of Chromatographic Conditions
Preliminary studies were aimed at determining the optimum sep-
aration conditions for analysis of perazine dimalonate using RP-
HPTLC system. As shown and mentioned in earlier papers,[1,3]
basic compounds such as perazine may cause chromatographic
separation difficulties using RP-LC due to their strong affinity
between their cationic and the anionic part of silanols. Some
peak tailing, unsatisfactory elution, or distortion of spots size
and image may occur during separation process. One of the stra-
tegies, aimed at reducing these interactions (electrostatic and/or
hydrophobic), is the use of ILs.[1,3,12,33] In this study, among dif-
ferent ILs [EMIm][BF4], a representative of imidazolium-based
ILs has been selected as a mobile phase modifier..
As an initial study, the separation of perazine was examined
with previously fixed mobile phase 1.5% (v/v) [EMIm][BF4]
with different ratios of acetonitrile (or methanol) and water in
the mobile phase. Graphical relationships between the retar-
dation factor (RF) of perazine and various mobile phase volume
compositions were plotted in Figure 2. Elution of tested sub-
stance without acetonitrile or methanol was insufficient due to
the strong specific interaction between basic perazine and the
stationary phase. The evident effect is observed at the organic
solvent concentration of 40% (v/v) and higher. However, elution
is much weaker when the methanol is added to the eluent.
Because the shape of the spot is mostly symmetrical for 1.5%
(v/v) [EMIm][BF4] in acetonitrile:water (60:40, v/v), this mobile
phase was used for further study.
Similar correlation was presented in Figure 3 with respect to
the RF values and the percentage additive of the selected IL in
the mobile phase. As is evident in the chart, elution of analyzed
compound did not change significantly over 1.5% (v/v) of
[EMIm][BF4]. In both cases, the sample spots were clear and
well separated at concentration ≥1.5% (v/v) of IL, whereas
when 0.5% (v/v) was used some tailing was observed. Finally,
a simple mixture of acetonitrile:water (60:40, v/v) with the
addition of 1.5% (v/v) of the 1-ethyl-3-methylimidazolium IL
was chosen as it was characterized by the best separation results:
round spot shape, optimal retention (RF¼ 0,43 0,02), and
quite brief elution (15min for 8 cm). Chromatographic system
containing methanol as a mobile phase component was unsatis-
factory and was discarded for further study due to the poor elu-
tion effect as RF was no greater than 0.2 in the range of 40–70
ratio volume of methanol.
Perazine Assay Results
In order to compare the effects of ILs with 1-ethyl-3-methylimi-
dazolium cation but different counterions, an attempt was made
to determine perazine dimalonate in pharmaceutical formulation
using RP-HPTLC system and different IL additive: [EMIm]
[BF4], [EMIm][Lac], and [EMIm][EtOSO3]. The study was to
investigate the effect of the anionic part of IL on the
hydrophobic interactions and the ability to assay perazine in
tablets.
Calibration curves were plotted based on the relationship
between peak area and drug quantity per spot. The equations
derived from the data are shown in a linear regression (Table 1).
Based on the quantitative and qualitative results, we have con-
cluded that the optimum phase for the determination of pharma-
ceutical formulation would be the system consisting of 1.5% of
tetrafluoroborate as it gave a high Pearson's correlation coef-
ficient of 0.9979 (for the linear indications) and 100.66% recov-
ery for tested drug. Admittedly, the system using ethyl sulfate
also gave good results (even better R¼ 0.9981), but with
slightly higher values scatter and deviations as it gave lower
RSD of the analysis 4.13% comparing to 3.66% for [EMIm]
[BF4] – which indicates that the use of tetrafluoroborate deter-
mines more precise indications. Recovery from the mobile
phase with [EMIm][EtOSO3] as a modifier was also worse than
from the [EMIm][BF4]. The separation of analyzed sample were
generally worse when L-(þ)-lactate was used, where the
discrepancy between the results (RSD¼ 6.97%) and the smal-
lest recovery could be observed.
Fig. 2. Graphical representation of the relationship between the
retention factor (RF) of perazine and the volume of organic com-
pound in the mobile phase with the use of 1.5% (v/v) [EMIm]
[BF4].
Fig. 3. Plot of retention factor (RF) of perazine against the concen-
tration of [EMIm][BF4] in the mobile phase: acetonitrile:water
(60:40, v/v).



















































Validation of the HPTLC Assay
The validation procedure of qualitative and quantitative determi-
nation of perazine in pharmaceutical formulation for the chosen
mobile phase composition containing tetrafluoroborate IL
additive (Table 2) was conducted in accordance with the ICH
guidelines and tested protocols.[26,34]
Specificity
Proposed RP-HPTLC method proved to be an adequate for a
separation of perazine dimalonate as no excipients from the
pharmaceutical formulation (Perazin 0.1 tablets) and any other
impurities were observed when comparing tracks and densito-
grams of developed plates (Figures 4 and 5); k¼ 247 nm, RF
values (0.43 0.02) of reference substance and sample were
both equal.
Linearity
The relationship between peak area (AU) and drug quantities
per spot found to be linear at a range of 0.80–2.20 µg (n¼ 8).
The regression equation determined by the method of least
squares was y¼ 1217.6x 265.83, with high correlation where
R was 0.9979. The linear correlation was checked and evaluated
by plotting residuals against drug quantity applied per spot. The
residuals showed no trends and were randomly dispersed above
and below the zero residual line, as it was shown in Figure 6.
Limit of Detection and Quantification
The limits of detection (LOD) and quantification (LOQ) are
given in Table 2 and their values were determined based on
the standard deviation of the response (r) and the slope (S) of
the achieved calibration curve for perazine. Detection and
quantification limit were evaluated according to the equations:
3.3 r/S and 10 r/S and their values were LOD¼ 0.11 and LOQ
¼ 0.34 [µg spot1].
Accuracy
Accuracy was appointed by means of recovery through the use
of synthetic mixtures of the drug. The solutions were made by
spiking a reference solution of perazine in a range of 80.0%,
100.0%, and 120.0% (concentrations, respectively, 1.2, 1.5,
1.8 µgmL1) with a lactose monohydrate, which is one of the
excipients and matrix component used in the tablet. The analyti-
cal procedure for preparation of these solutions was performed
as with the extracts and assessed within the specified range (3
concentrations/3 replicates each). The values of proposed
method in sequence 103.04%, 99.04%, and 99.75% found to
be satisfactory and indicated good accuracy of the proposed
method.
Precision
The values of relative standard deviation (% RSD) were estab-
lished by analyzing three different standard drug solutions
applied on a plate as spots containing, respectively, 1.0, 1.4,
1.8 µg three times within the same day and operating conditions
(intra-day) and by repeating studies in the next two following
days (inter-day). Data are shown in Table 3. The low results
obtained (not greater than 3.46% at the lowest concentration)
indicated well precision of carried out determination.
Robustness
Our proposed method has proven to be robust, as changes in
temperature (20 3°C), size of chromatographic chamber
(20 20 cm or 10 15 cm) or the wavelength in the study did
not change substantially the results obtained in the analysis.
Discussion
Commercially available pharmaceutical formulation was suc-
cessfully determined with the proposed RP-HPTLC method.
No interference has been observed from the tablet excipients.
No additional spots were observed during analysis, whereas
Table 2. Validation of quantitative analysis of perazine dimalonate
by HPTLC densitometry with a use of [EMIm][BF4] ionic liquid as
a mobile phase modifier
Parameters [EMIm][BF4]
Specificity Specific
Range (µg spot1) 0.80 2.20
Regression equation y¼ 1217.6x 265.83
R 0.9979
Limit of detection [LOD] (µg spot1) 0.11





Fig. 4. Reference plates for perazine developed under various
chromatographic conditions. Mobile phase: (a) acetonitrile:water
(60:40, v/v), (b) acetonitrile:water (60:40, v/v) with decreased pH
to 4.32, (c) acetonitrile:water (60:40, v/v) with 1.5% of [EMIm]
[BF4], (d) acetonitrile:water (60:40, v/v) with 1.5% of [EMIm]
[EtOSO3], and (e) acetonitrile:water (60:40, v/v) with 1.5% of
[EMIm][Lac].



















































λmax (247 nm) and RF values (respectively, 0.43, 0.43, and
0.23 0.02 for [EMIm][BF4], [EMIm][EtOSO3], and [EMIm]
[Lac]) were equal both for a reference substance and a test
sample. Aforementioned representative RP-HPTLC plates are
presented in Figure 4.
Comparison of retention and obtained quantitative data in the
RP-HPTLC system confirmed the positive effect of the use of
ILs in liquid chromatography and separation of basic com-
pounds. However, the use of different ILs resulted in a slightly
different peak symmetry and shape. Good symmetrical peaks
were observed when [EMIm][BF4] and [EMIm][EtOSO3] were
used, whereas utilization of [EMIm][Lac] caused peak distortion
showing some tailing and asymmetry. It may be related to the
occurrence of a background, which could interfere with silica
gel as a carrier and thus lead to inaccurate determinations using
reflectance densitometry scanning. This phenomenon occurred
only with the use of [EMIm][Lac] as an additive.
In all cases, significant change in the pH values was observed
before and after the addition of a mobile phase modifier
(Table 1), hence the influence of the mobile phase pH on the
retention behavior was also studied. In the first experiment, it
was revealed that the mobile phase acetonitrile:water (60:40,
v/v) without any additive (pH ca. 6.0) caused neither clear sep-
aration nor elution of studied compounds (Figure 4a). Next,
after positive results in the separation process using [EMIm]
[BF4] an experiment was conducted in which pH of the mobile
phase was decreased from 6.0 to 4.3 (corresponding to [EMIm]
[BF4], with the use of citric acid monohydrate). But even the
Fig. 5. Densitogram for perazine standard (a) and tablets (b) by RP-HPTLC, with a mobile phase of acetonitrile:water (60:40, v/v) and
1.5% addition of [EMIm][BF4], showing no interference with the excipients in the analysis and the compatibility of RF values of (a) and
(b). The difference in peak height and area is associated with scanning of randomly selected standard spot.
Table 3. Precision of validated RP-HPTLC method
Concentration (µ gmL)
Intra-day Inter-day
Meana SD RSD (%) Meana SD RSD (%)
1.0 944.3 32.65 3.46 730.57 24.27 3.32
1.4 1356.29 26.03 1.92 1102.90 28.67 2.60
1.8 1731.45 40.73 2.35 1454.12 28.64 1.97
an¼ 3 replicates each.
Fig. 6. Linear calibration curve (a) under optimized chromato-
graphic condition and its residuals plot (b).



















































adjustment of experimental pH to the desired level did not
significantly affect the retention of compounds (Figure 4b).
Lack of elution clearly pointed out that the obtained results
are attributable only to the remarkable properties of ILs and
their suppressing potency of free silanol.[3]
Conclusions
The evidence from presented study documents that 1-ethyl-3-
methylimidazolium-based ILs are valuable and efficient sup-
pressors of free silanols which are responsible for unwanted
interactions of chromatographic stationary phases in chromato-
graphy of basic compounds. Comparison study between three
different ILs with same cation but different counterions as addi-
tives to mobile phase proved also the significant influence of
anionic part into the mechanism of action during the chromato-
graphy of perazine with the use of RP stationary phase. More-
over, the chromatographic separation produced by 1-ethyl-3-
methylimidazolium ILs are not due to the pH change caused
by the additive/different anion. In view of the results obtained
here, both imidazolium cations as well as anions of ILs are
responsible for effect of changing retention of perazine in
RP-HPTLC.
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